Refinement of the 22q12-q13 breast cancer-associated region: Evidence of TMPRSS6 as a candidate gene in an eastern Finnish population

Clinical Cancer Research

Volumn 12, Issue 5, 2006, Pages 1454-1462

  Hartikainen, Jaana M ^a,b   Tuhkanen, Hanna ^a,b   Kataja, Vesa ^b   Eskelinen, Matti ^b   Uusitupa, Matti ^a   Kosma, Veli Matti ^a,b   Mannermaa, Arto ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CANDIDATE GENE; CASE CONTROL STUDY; CHROMOSOME 22Q; CONTROLLED STUDY; FINLAND; GENE; GENE LOCUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TMPRSS6 GENE;

ALLELIC IMBALANCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SERINE ENDOPEPTIDASES;

EID: 33645053497     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1417     Document Type: Article

References (23)

1. Thompson D, Easton D. The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 2004;9:221-36.
2. Laitinen T, Polvi A, Rydman P, et al. Characterization of a common susceptibility locus for asthma-related traits. Science 2004;304:300-4.
3. Norio R. Finnish disease heritage I: characteristics, causes, background. Hum Genet 2003a;112:441-56.
4. Norio R. Finnish disease heritage II: population prehistory and genetic roots of Finns. Hum Genet 2003b;112:457-69.
5. Hartikainen JM, Tuhkanen H, Kataja V, et al. An autosome wide scan for linkage disequilibrium based association in sporadic breast cancer cases in Eastern Finland: three candidate regions found. Cancer Epidemiol Biomarkers Prev 2005;14:75-80.
6. Allione F, Eisinger F, Parc P, Noguchi T, Sobol H, Birnbaum D. Loss of heterozygosity at loci from chromosome arm 22q in human sporadic breast carcinomas. Int J Cancer 1998;75:181-6.
7. Iida A, Kurose K, Isobe R, et al. Mapping of a new target region of allelic loss to a 2-cm interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer 1998;21:108-12.
8. Bryan EJ, Thomas NA, Palmer K, Dawson E, Englefield P, Campbell IG. Refinement of an ovarian cancer tumour suppressor gene locus on chromosome arm 22q and mutation analysis of CYP2D6, SREBP2 and NAGA. Int J Cancer 2000;87:798-802.
9. Castells A, Gusella JF, Ramesh V, Rustgi AK. A region of deletion on chromosome 22q13 common to human breast and colorectal cancers. Cancer Res 2000;60:2836-9.
10. Hirano A, Emi M, Tsuneizumi M, et al. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer. Clin Cancer Res 2001;7:876-82.
11. Männistö S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M. Body size indicators and risk of breast cancer according to menopause and estrogen receptor status. Int J Cancer 1996;68:8-13.
12. Vandenplas S, Wiid J, Grobler Rabie A, et al. Blot hybridization of genomic DNA. J Med Genet 1984;21:164-72.
13. Tuhkanen H, Anttila M, Kosma VM, et al. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int J Cancer 2004;109:247-52.
14. Karjalainen JM, Kellokoski JK, Mannermaa AJ, et al. Failure in post transcriptional processing is a possible inactivation mechanism of AP-2α in cutaneous melanoma. Br J Cancer 2000;82:2015-21.
15. Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002;11:1399-407.
16. Slatkin M, Excoffier L. Testing for linkage disequilibrium in genotypic data using the expectation-maximization algorithm. Heredity 1996;76:377-83.
17. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995;29:311-22.
18. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-50.
19. Finnish Cancer Registry. Cancer Statistics for Finland, March 2, 2004. http://www.cancerregistry.fi/.
20. Velasco G, Cal S, Quesada V, Sanchez LM, Lopes-Otin C. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem 2002;277:37637-46.
21. Overall CM, Tam EM, Kappelhoff R, et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol Chem 2004;385:493-504.
22. Ertekin-Taner N, Ronald J, Feuk L, et al. Elevated amyloid β protein (Aβ42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum Mol Genet 2005;14:447-60.
23. Rioux JD, Daly MJ, Silverberg MS, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001;29:223-8.